BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plavc G, Strojan P. Combining radiotherapy and immunotherapy in definitive treatment of head and neck squamous cell carcinoma: review of current clinical trials. Radiol Oncol 2020;54:377-93. [PMID: 33064670 DOI: 10.2478/raon-2020-0060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Altay-Langguth A, Balermpas P, Brandts C, Balster S, Ghanaati S, Winkelmann R, Burck I, Rödel F, Martin D, Rödel C, von der Grün J. Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study. Clin Transl Radiat Oncol 2021;28:71-8. [PMID: 33889760 DOI: 10.1016/j.ctro.2021.03.004] [Reference Citation Analysis]
2 Bozic T, Sersa G, Kranjc Brezar S, Cemazar M, Markelc B. Gene electrotransfer of proinflammatory chemokines CCL5 and CCL17 as a novel approach of modifying cytokine expression profile in the tumor microenvironment. Bioelectrochemistry 2021;140:107795. [PMID: 33789177 DOI: 10.1016/j.bioelechem.2021.107795] [Reference Citation Analysis]
3 Masarwy R, Kampel L, Horowitz G, Gutfeld O, Muhanna N. Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 2021;147:871-8. [PMID: 34473219 DOI: 10.1001/jamaoto.2021.2191] [Reference Citation Analysis]
4 Chitsike L, Duerksen-Hughes PJ. Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review. Front Oncol 2021;11:730412. [PMID: 34490123 DOI: 10.3389/fonc.2021.730412] [Reference Citation Analysis]
5 Sun C, Zhang M, Qiao Q, Wang Y. Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma. Med Sci Monit 2021;27:e932126. [PMID: 34670999 DOI: 10.12659/MSM.932126] [Reference Citation Analysis]
6 Farlow JL, Brenner JC, Lei YL, Chinn SB. Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment. Oral Oncol 2021;120:105420. [PMID: 34218062 DOI: 10.1016/j.oraloncology.2021.105420] [Reference Citation Analysis]
7 Sellami S, Leclere JC, Lucia F, Gobel Y, Uguen A, Rousset J, Gouders D, Pradier O, Marianowski R, Abgral R, Schick U. N3 (> 6 cm) squamous cell carcinoma of the head and neck: outcomes and predictive factors in 104 patients. Acta Otorhinolaryngol Ital 2021;41:221-9. [PMID: 34264915 DOI: 10.14639/0392-100X-N1437] [Reference Citation Analysis]